Long-Term Safety Analysis of a Fibrinogen Concentrate (RiaSTAP/Haemocomplettan P)
Fibrinogen concentrate treatment is recommended for acute bleeding episodes in adult and pediatric patients with congenital and acquired fibrinogen deficiency. Previous studies have reported a low risk of thromboembolic events (TEEs) with fibrinogen concentrate use; however, the post-treatment TEE r...
Salvato in:
| Autori principali: | , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
SAGE Publishing
2024-05-01
|
| Serie: | Clinical and Applied Thrombosis/Hemostasis |
| Accesso online: | https://doi.org/10.1177/10760296241254106 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|